OF THE
TIMES

Back in February 2020, long before lockdowns were rolled out in the Western world, someone made the connection of how components of the SARS-CoV-2 spike protein (glycoprotein S) are homologous to some of our human endogenous retroviruses - the viruses that are found in our DNA. Pfizer's mRNA vaccine is designed to produce the SARS-CoV-2 spike protein in the human body.
Various researchers have brought to our attention the concept of viral recombination: when two viruses meet, they are very effective at exchanging genetic material between each other and a new recombined virus can be generated from this exchange. Due to the properties of our own DNA, we might not just be looking here at the arrival of a new recombined flu-like virus (the coronavirus of the vaccine + a flu virus in our cells), but - in the worst case scenario - to the recombining of a virus that is far more deadly.


Comment: It was recently discovered that Ebola can remain in the system and cause an antibody spike 6 months after the initial infection, possibly causing the carrier to become infectious again.
See also: